--- title: "From January 1, 2023 to January 2025, many companies saw the highest stock price increases, with som" description: "From January 1, 2023 to January 2025, many companies saw the highest stock price increases, with some even experiencing growth of dozens of times.This stock list includes the top 30 companies with the" type: "topic" locale: "en" url: "https://longbridge.com/en/topics/26751705.md" published_at: "2025-01-23T10:46:31.000Z" author: "[官方股单 ](https://longbridge.com/en/profiles/8795959)" --- # From January 1, 2023 to January 2025, many companies saw the highest stock price increases, with som From January 1, 2023 to January 2025, many companies saw the highest stock price increases, with some even experiencing growth of dozens of times. This stock list includes the top 30 companies with the highest growth rates, among which, the first place is AppLovin, with a 2917% increase; $AppLovin(APP.US) the second place is Microstrategy, with a 1897% increase; $Strategy(MSTR.US) the third place is Palantir Tech, with a 1083% increase; $Palantir Tech(PLTR.US) the fourth place is NVIDIA, with a 839% increase; $NVIDIA(NVDA.US) the fifth place is Vistra, with a 543% increase; $Vistra(VST.US) the sixth place is Royal Caribbean Cruises, with a 376% increase; $Royal Caribbean Cruises(RCL.US) Other strong performers include Tesla and Broadcom. $Tesla(TSLA.US)$Broadcom(AVGO.US) Data scope: Dow Jones Industrial Average constituents + S&P 500 constituents + Nasdaq 100 constituents ### Related Stocks - [APP.US - AppLovin](https://longbridge.com/en/quote/APP.US.md) - [MSTR.US - Strategy](https://longbridge.com/en/quote/MSTR.US.md) - [PLTR.US - Palantir Tech](https://longbridge.com/en/quote/PLTR.US.md) - [NVDA.US - NVIDIA](https://longbridge.com/en/quote/NVDA.US.md) - [VST.US - Vistra](https://longbridge.com/en/quote/VST.US.md) - [RCL.US - Royal Caribbean Cruises](https://longbridge.com/en/quote/RCL.US.md) - [TSLA.US - Tesla](https://longbridge.com/en/quote/TSLA.US.md) - [AVGO.US - Broadcom](https://longbridge.com/en/quote/AVGO.US.md) --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.